ID

26214

Descrição

Hypertension in Breast Cancer Patients Receiving Bevacizumab; ODM derived from: https://clinicaltrials.gov/show/NCT00674011

Link

https://clinicaltrials.gov/show/NCT00674011

Palavras-chave

  1. 11/10/2017 11/10/2017 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

11 de outubro de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Breast Cancer NCT00674011

Eligibility Breast Cancer NCT00674011

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed breast cancer
Descrição

Breast Carcinoma

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0678222
must be starting combination treatment with bevacizumab and chemotherapy. treatment may not have already started. patients may receive therapy either on or off of a clinical trial.
Descrição

Combined Modality Therapy | bevacizumab | Chemotherapy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0009429
UMLS CUI [2]
C0796392
UMLS CUI [3]
C0392920
any number of prior chemotherapy or biological therapy regimens is acceptable.
Descrição

Prior Chemotherapy Quantity | Biological treatment Quantity

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C1265611
UMLS CUI [2,1]
C1531518
UMLS CUI [2,2]
C1265611
either no history of hypertension, defined as blood pressure <140/90mm hg on no antihypertensive therapy, or medically controlled pre-existing hypertension, defined as blood pressure < 140/90mm hg on one non-angiotensin converting enzyme inhibitor (ace-i) or non-angiotensin receptor blocking (arb) medication.
Descrição

Hypertensive disease Absent | Blood Pressure | Antihypertensive therapy Absent | Hypertensive disease Pre-existing Controlled | Pharmaceutical Preparations Without Angiotensin-Converting Enzyme Inhibitors | Pharmaceutical Preparations Without Angiotensin II receptor antagonist

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0020538
UMLS CUI [1,2]
C0332197
UMLS CUI [2]
C0005823
UMLS CUI [3,1]
C0585941
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C0020538
UMLS CUI [4,2]
C2347662
UMLS CUI [4,3]
C2911690
UMLS CUI [5,1]
C0013227
UMLS CUI [5,2]
C0332288
UMLS CUI [5,3]
C0003015
UMLS CUI [6,1]
C0013227
UMLS CUI [6,2]
C0332288
UMLS CUI [6,3]
C0521942
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of uncontrolled hypertension within the previous 6 months
Descrição

Uncontrolled hypertension

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1868885
inability to assess blood pressure or have prolonged blood pressure cuff inflation due to history of bilateral lymph node dissections, presence of an indwelling venous access device, or other condition
Descrição

Blood pressure assessment Unable | Lymph Node Dissection Bilateral | Venous access device implantation

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1161105
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C0242382
UMLS CUI [2,2]
C0238767
UMLS CUI [3]
C1700941
concurrent use of a statin medication
Descrição

Statins

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0360714
systolic blood pressure < 100mm hg
Descrição

Systolic Pressure

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0871470

Similar models

Eligibility Breast Cancer NCT00674011

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Breast Carcinoma
Item
histologically or cytologically confirmed breast cancer
boolean
C0678222 (UMLS CUI [1])
Combined Modality Therapy | bevacizumab | Chemotherapy
Item
must be starting combination treatment with bevacizumab and chemotherapy. treatment may not have already started. patients may receive therapy either on or off of a clinical trial.
boolean
C0009429 (UMLS CUI [1])
C0796392 (UMLS CUI [2])
C0392920 (UMLS CUI [3])
Prior Chemotherapy Quantity | Biological treatment Quantity
Item
any number of prior chemotherapy or biological therapy regimens is acceptable.
boolean
C1514457 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1531518 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Hypertensive disease Absent | Blood Pressure | Antihypertensive therapy Absent | Hypertensive disease Pre-existing Controlled | Pharmaceutical Preparations Without Angiotensin-Converting Enzyme Inhibitors | Pharmaceutical Preparations Without Angiotensin II receptor antagonist
Item
either no history of hypertension, defined as blood pressure <140/90mm hg on no antihypertensive therapy, or medically controlled pre-existing hypertension, defined as blood pressure < 140/90mm hg on one non-angiotensin converting enzyme inhibitor (ace-i) or non-angiotensin receptor blocking (arb) medication.
boolean
C0020538 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0005823 (UMLS CUI [2])
C0585941 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0020538 (UMLS CUI [4,1])
C2347662 (UMLS CUI [4,2])
C2911690 (UMLS CUI [4,3])
C0013227 (UMLS CUI [5,1])
C0332288 (UMLS CUI [5,2])
C0003015 (UMLS CUI [5,3])
C0013227 (UMLS CUI [6,1])
C0332288 (UMLS CUI [6,2])
C0521942 (UMLS CUI [6,3])
Item Group
C0680251 (UMLS CUI)
Uncontrolled hypertension
Item
history of uncontrolled hypertension within the previous 6 months
boolean
C1868885 (UMLS CUI [1])
Blood pressure assessment Unable | Lymph Node Dissection Bilateral | Venous access device implantation
Item
inability to assess blood pressure or have prolonged blood pressure cuff inflation due to history of bilateral lymph node dissections, presence of an indwelling venous access device, or other condition
boolean
C1161105 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0242382 (UMLS CUI [2,1])
C0238767 (UMLS CUI [2,2])
C1700941 (UMLS CUI [3])
Statins
Item
concurrent use of a statin medication
boolean
C0360714 (UMLS CUI [1])
Systolic Pressure
Item
systolic blood pressure < 100mm hg
boolean
C0871470 (UMLS CUI [1])

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial